All articles tagged with #biosecure act
WuXi AppTec was added to the Pentagon's 1260H list under the Biosecure Act, labeling it as a Chinese military-connected company and potentially restricting U.S. federal funding for equipment or services; WuXi denies any military affiliation, says designation is erroneous, and plans to pursue removal while analysts anticipate limited disruption due to grandfathering and ongoing U.S. expansion plans.
The BIOSECURE Act, which aims to restrict U.S. pharmaceutical companies from using Chinese contract manufacturers like WuXi AppTec and WuXi Biologics, was excluded from a crucial defense budget bill. This legislation, supported by both parties, seeks to reduce reliance on China in the drug supply chain and maintain U.S. dominance in biotechnology. However, the exclusion from the defense bill represents a significant setback for the act.
Negotiators on a key US defense bill decided not to include the Biosecure Act, which would have blacklisted five Chinese-linked biotechnology firms from federally funded research and contracts. Despite earlier support from the House and a bipartisan group in the Senate, senior House Democrats objected to naming specific companies in the legislation, resulting in a win for the Chinese biotech firms.